The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

Clinical trial NCT06115603 · RECRUITING

Trial details

NCT number: NCT06115603
Sponsor: University of Arkansas, Fayetteville
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2024-12-14
Primary completion: 2026-07-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.